Ampio Pharmaceuticals Profile

1.09
USD 0.02  1.8%
0.61Last Month High 1.15 
1.02Trading Day  High 1.17 

Acquisition by Richard Giles of 30000 shares of Ampio Pharmaceuticals subject to Rule 16b-3

Ampio Pharmaceuticals Inc insider trading alert for grant of stock option (right to buy) by Richard Giles, the corporate stakeholder, on September 28, 2017. This event was filed by Ampio Pharmaceuticals Inc with SEC on 2017-09-28. Statement of changes in beneficial ownership - SEC Form 4. Richard Giles is currently serves as director of investor relations, director, chairman of audit committee, member of nominating and governance committee and member of compensation committee of Ampio Pharmaceuticals Inc [view details]   

Ampio Pharmaceuticals Summary

Ampio Pharmaceuticals Inc (AMPE) is traded on American Stock Exchange in USA. It is located in COLORADO, U.S.A and employs 21 people. Ampio Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with current market capitalization of 74.37 M. Ampio Pharmaceuticals Inc has 68.23 M outstanding shares of which 5.23 M shares are presently shorted by private and institutional investors with about 15.47 trading days to cover. AMPIO PHARMACEUTI currently holds about 5 M in cash with (10.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07.
Check Ampio Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Carnick Kubik Group LlcCommon Shares140.6 K86 K
Jfs Wealth Advisors LlcCommon Shares18.1 K11 K
View Ampio Pharmaceuticals Diagnostics

Selected Ampio Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Ampio Pharmaceuticals Against Markets

Current Ratings  

Ampio Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
20 
Chance of
< 51% 
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing therapies for the treatment of prevalent inflammatory conditions in the United States. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAmpio Pharmaceuticals Inc
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationCOLORADO, U.S.A
Business AddressAmpio Pharmaceuticals, Inc.Englewood, CO
ExchangeAmerican Stock Exchange
CIK Number01411906.0
CUSIP03209T109
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.ampiopharma.com
Contact Number720 437 6500
CurrencyUSD - US Dollar

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Executives

Ampio Pharmaceuticals Corporate Executives
Thomas Chilcott Interim CFO
Gregory Gould CFO, Treasurer, Corporate Secretary
Holli Cherevka COO